Clinical Trials Browser

Phase 1/2 × Interleukin 1 Receptor Antagonist Protein × 1 year × Clear all

NCT05013450 2025-12-17

Dupilumab_Metastatic NSCLC

Phase 1/2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06703216 2025-06-15

PACER

Phase 1/2 Not yet recruiting

Cytokine Release Syndrome, Burkitt Lymphoma